Acute Exercise on Brain Insulin Sensitivity
Impact of Acute Exercise on Brain Insulin Sensitivity in Middle-aged to Older Adults
1 other identifier
interventional
16
1 country
4
Brief Summary
Dementia is a leading cause of death in the United States among aging adults. Brain insulin resistance has emerged as a pathologic factor affecting memory, executive function as well as systemic glucose control. Regular aerobic exercise decreases Alzheimer's Disease (AD) risk, in part, through changes in brain structure and function. However, there is limited data available on how exercise impacts brain insulin resistance in aging. This study will test the effect of acute exercise on brain insulin sensitivity in middle-aged to older adults. The study will also examine cognition and cardiometabolic health in relation to brain insulin sensitivity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 19, 2023
CompletedFirst Posted
Study publicly available on registry
May 11, 2023
CompletedStudy Start
First participant enrolled
May 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 25, 2025
CompletedNovember 21, 2025
November 1, 2025
1.9 years
April 19, 2023
November 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Brain insulin sensitivity
MRI arterial spin labeling, cerebral blood flow
Change from baseline to exercise; about 1 week apart
Secondary Outcomes (5)
Cognition
Change from baseline to exercise; about 1 week apart
Blood Glucose
Change from baseline to exercise; about 1 week apart
Blood Free Fatty Acids
Change from baseline to exercise; about 1 week apart
Carbohydrate Use
Change from baseline to exercise; about 1 week apart
Systolic and Diastolic Blood Pressure
Change from baseline to exercise; about 1 week apart
Study Arms (2)
Rest
NO INTERVENTIONIndividuals will rest for about 1 hour in the seated position to mimic time exercising.
Exercise
EXPERIMENTALIndividuals will exercise for at medium to hard intensity for 1 hour.
Interventions
Exercise will be walking/jogging at a medium to hard intensity for 1 hour.
Eligibility Criteria
You may qualify if:
- Male or female \>/=40 and \</=80 years old.
- Has a body mass index \>/=25 and \</=45 kg/m2.
- Physical Activity (\<150 min of moderate/high intensity exercise per week)
You may not qualify if:
- Subjects who have not been weight stable (\>2 kg weight change in past 3 months)
- Subjects who are smokers or who have quit smoking \<1 years ago
- Subjects with abnormal estimated glomerular filtration rate (eGFR).
- Hypertriglyceridemic (\>400 mg/dl) and hypercholesterolemic (\>260 mg/dl) subjects
- Hypertensive (\>160/100 mmHg)
- Subjects with a history of significant metabolic, cardiac, congestive heart failure, cerebrovascular, hematological, pulmonary, gastrointestinal, liver, renal, or endocrine disease or cancer that in the investigator's opinion would interfere with or alter the outcome measures or impact subject safety.
- Pregnant (as evidenced by positive urine pregnancy test) or nursing women
- Subjects with contraindications to participation in an exercise
- Current Pregnancy
- Currently taking active weight suppression medication (e.g. phentermine, orlistat, lorcaserin, naltrexone-bupropion in combination, liraglutide, benzphetamine, diethylpropion, phendimetrazine)
- Subjects currently taking medications that affect heart rate and rhythm (i.e. Ca++ channel blockers, nitrates, alpha- or beta-blockers).
- Known contraindications for MRI imaging
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Institute for Food, Nutrition, and Health
New Brunswick, New Jersey, 08901, United States
Robert Wood Johnson University Hospital Clinical Research Center
New Brunswick, New Jersey, 08901, United States
Rutgers University Loree Gymnasium
New Brunswick, New Jersey, 08901, United States
Center for Advanced Human Brain Imaging Research
Piscataway, New Jersey, 08854, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven K Malin, PhD
Rutgers University - New Brunswick
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 19, 2023
First Posted
May 11, 2023
Study Start
May 11, 2023
Primary Completion
March 20, 2025
Study Completion
March 25, 2025
Last Updated
November 21, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share